These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5323047)

  • 21. [Endolymphatic use of drug preparations in the treatment of malignant tumors of the lymphatic system].
    Kuliev ShB
    Probl Gematol Pereliv Krovi; 1969 Feb; 14(2):14-7. PubMed ID: 5394760
    [No Abstract]   [Full Text] [Related]  

  • 22. [Chronic leukemia therapy with trenimon].
    Rattka P
    Pol Tyg Lek; 1965 Dec; 20(49):1857-8. PubMed ID: 5867901
    [No Abstract]   [Full Text] [Related]  

  • 23. [Non-Hodgkin lymphoma becomes curable].
    Krankenpfl J; 2005; 43(1-3):40-1. PubMed ID: 15912832
    [No Abstract]   [Full Text] [Related]  

  • 24. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
    Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
    Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Some reflections on the favorable effects of chlorambucil in unusual doses].
    Kissel P; Debry G; Royer R; Picard L
    Ann Med Nancy; 1965 Dec; 4():1133-5. PubMed ID: 5898202
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapeutic agents in childhood malignancies.
    Ching LT; Burgert EO; Mills SD
    Mayo Clin Proc; 1970 Jan; 45(1):36-42. PubMed ID: 4312404
    [No Abstract]   [Full Text] [Related]  

  • 27. Rituxan: the new kid on the block.
    Jonas C
    Oncol Nurs Forum; 1998 May; 25(4):669. PubMed ID: 9599347
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of the therapeutic effect of lycurim in lymphoma.
    Kotlarek-Haus S; Frydecka I; Gatazka Z; Gabryś K
    Ther Hung; 1981; 29(3):124-7. PubMed ID: 6897914
    [No Abstract]   [Full Text] [Related]  

  • 29. [Guidelines in the therapy of various neoplastic diseases with cytostatic drugs].
    Bollag W
    Praxis; 1969 Jun; 58(22):703-7. PubMed ID: 5258076
    [No Abstract]   [Full Text] [Related]  

  • 30. [CNS involvement in non-Hodgkin lymphomas. Clinical aspects and therapy (author's transl)].
    Hennemann HH; Ranft K; Weiss A; Mantel W; Lengfelder E
    MMW Munch Med Wochenschr; 1981 Dec; 123(51-52):1975-7. PubMed ID: 6798435
    [No Abstract]   [Full Text] [Related]  

  • 31. [Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
    Kondrat'eva NA; Makhonova LA; Maiakova SA; Vialushkin BIa
    Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):12-6. PubMed ID: 7015318
    [No Abstract]   [Full Text] [Related]  

  • 32. Intra-articular use of cytostatica. (Thio-Tepa, Azetepa and Osmium acid).
    Langkilde M; Rossel I
    Acta Rheumatol Scand; 1967; 13(2):92-100. PubMed ID: 4961259
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of alkylating cytostatics on the development of secondary malignant tumors].
    Galajda P; Donner L
    Vnitr Lek; 1984 Aug; 30(8):756-63. PubMed ID: 6506498
    [No Abstract]   [Full Text] [Related]  

  • 34. [Critical evaluation of the clinical use of new histopathological classifications of non-Hodgkin lymphomas].
    Poccardi G; Urbano D; Torchio B; Giovanelli E; Sabbaa S; Neretto G
    Recenti Prog Med; 1982 Apr; 72(4):417-45. PubMed ID: 6755582
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chemotherapy and immuno-chemotherapy in malignant lymphoma].
    Nishikori M; Nasu K; Shirakawa S; Karitani Y
    Rinsho Ketsueki; 1983 Apr; 24(4):320-9. PubMed ID: 6350639
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the problems of transition of chronic myelosis into reticulum cell sarcoma].
    Helbig W; Lohse U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 84(2):190-204. PubMed ID: 4161255
    [No Abstract]   [Full Text] [Related]  

  • 37. [Betamethasone in the treatment of acute lymphatic leukosis and other lymphoproliferative diseases].
    Invernizzi R
    Minerva Med; 1980 Nov; 71(44):3247-50. PubMed ID: 6935535
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B; Santos ES
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):257-73. PubMed ID: 17338647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group].
    Forstpointner R; Hänel A; Repp R; Hermann S; Metzner B; Pott C; Hartmann F; Rothmann F; Böck HP; Wandt H; Unterhalt M; Hiddemann W
    Dtsch Med Wochenschr; 2002 Oct; 127(43):2253-8. PubMed ID: 12397539
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AMSA therapy for children with lymphoblastic malignancy.
    Hutter JJ; Meyskens FL
    Cancer Treat Rep; 1982 Mar; 66(3):593-4. PubMed ID: 6949644
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.